US74907L3006 - QNRX - A3EJL7 (XNCM)

QUOIN PHARMAC.ADR 60000 Depository Receipt

0,48 EUR

-3,85 % -0,02 EUR 24.12.2024 21:50 - EUR - Frankfurt (XNAS) - Current prices and charts at MoneyPeak

Current Prices from QUOIN PHARMAC.ADR 60000

Exchange	Ticker	Currency	Last Trade	Price	Daily Change	Daily Change %
NASDAQ	QNRX	USD	24.12.2024 21:50	0,50 USD	0,52 USD	-4,21 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-9,66 %	-14,16 %	0,48 %	-16,98 %	-87,84 %	-99,96 %

Company Profile for QUOIN PHARMAC.ADR 60000 Depository Receipt

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Company Data QUOIN PHARMAC.ADR 60000 Depository Receipt

Name QUOIN PHARMAC.ADR 60000

Company Quoin Pharmaceuticals, Ltd.

Symbol QNRX

Website https://quoinpharma.com

Primary Exchange

Frankfurt

WKN A3EJL7

ISIN US74907L3006

Asset Class Depository Receipt

Sector Healthcare

Industry Biotechnology

CEO Dr. Michael Myers Ph.D.

Country United States of America

Currency EUR

Employees 0,0 T

Address 42127 Pleasant Forest Court, 20148-7349 Ashburn

IPO Date 2016-08-01

ID Changes

Date	From	To
29.10.2021	APOP	QNRX

Ticker Symbols

Name	Symbol
NASDAQ	QNRX

More Shares

Investors who QUOIN PHARMAC.ADR 60000 hold also have the following shares in their portfolio:

EBRD 24/27 MTN Bond

Kinetics Market Opportunities Fund Fonds

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog